Altered serum lipoproteins and apolipoproteins in carotid atherosclerosis

Cerebrovascular Diseases

Volumn 6, Issue 1, 1996, Pages 21-27

  Kataoka, Satoshi ^a   Saigan, Tsukasa ^a   Michishita, Hidenobu ^a   Hori, Ariyuki ^a   Hirose, Genjiro ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apolipoprotein; Atherosclerosis; Carotid atherosclerosis; Lipoprotein; Risk factors in atherosclerosis

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN METABOLISM; STROKE;

EID: 0030026802     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000107988     Document Type: Article

References (43)

1. Yatsu FM, Fisher M: Atherosclerosis-. Current concepts on pathogenesis and interventional therapies. Ann Neurol 1989;26:3-12.
2. van Merode T. Hick P. Hocks APG. Rencman RS: Serum HDL/total cholesterol ratio and blood pressure in asymptomatic atherosclerotic lesions of the cervical carotid arteries in men. Stroke 1985:16:34-38.
3. Postiglionc A, Rubba P, Dc Simone B, Patti L, Cicerano U, Mancini M: Carotid atherosclerosis in familial hypercholesterolemia. Stroke 1985:16:658-661.
4. Ford CS, Crouse JR, Howard G, Toole JF, Ball MR, Frye J: The role of plasma lipids in carotid bifurcation atherosclerosis. Ann Neurol 1985; 17:301-303.
5. Grotta JC, Yatsu FM. Pettigrew LC, Rhoades H. Bratina P. Vital RN, Alam R. Earls R, Picone C: Prediction of carotid stenosis progression by lipid and hematologic measurements. Neurology 1989;39:1325-1331.
6. Woo J, Lau E. Lam CWK, Kay R, Teoh R. Wong HL. Prall WY, Krcel L, Nicholls MG: Hypertension, lipoprotein (a) and apolipopro-tein A-l as risk factors for stroke in the Chinese. Stroke 1991:22:203-208.
7. Yasaka M, Yamaguchi T, Shichiri M: Distribution of atherosclerosis and risk factors in athe-rothrombotic occlusion. Stroke 1993:24:206-211.
8. Bogousslavskv J, Regli F, van Melle G: Risk factors and concomitants of internal carotid artery occlusion or stenosis. A controlled study of 159 cases. Arch Neurol 1985;42:864-867.
9. Rubens J, Espeland MA. Ryu J. Harpold G, McKinney WM, Kahl FR, Tool JF, Crouse JR: Individual variation in susceptibility to extra-cranial carotid atherosclerosis. Arteriosclerosis 1988;8:389-397.
10. Craven TE. Ryu JE, Espeland MA. Kahl FR. McKinney WM, Toole JF. McMahan MR, Thompson CJ. Heiss G, Crouse JR: Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. Circulation 1990:82:1230- 1242.
11. Crouse JR, Toole JF, McKinney WM, Dignan MB, Howard G, Kahl FR. McMahan MR, Harpold GH: Risk factors for extracranial carotid artery atherosclerosis. Stroke 1987:18:990-996.
12. Jenkins CD: Recent evidence supporting psychologic and social risk factors for coronary disease. I. N Engl J Med 1976:294:987-994.
13. Jenkins CD: Recent evidence supporting psychologic and social risk factors for coronary disease. II. N Engl J Med 1976:294:1033-1038.
14. Ingall TJ, Homer D, Baker HL, Kottke BA, O'Fallon WM. Whisnant JP: Predictors of intracranial carotid artery atherosclerosis: Duration of cigarette smoking and hypertension are more powerful than serum lipid levels. Arch Neurol 1991;48:687-691.
15. Homer D, Ingall TJ, Baker HL. O’Fallon WM. Kottke BA, Whisnant JP: Serum lipids and lipoproteins are less powerful predictors of extracranial carotid artery atherosclerosis than are cigarette smoking and hypertension. Mayo Clin Proc 1991:66:259-267.
16. Passero S. Rossi G, Nardini M. Bonelli G, D’Ettore M, Martini A. Battistini N, Albanese V, Bono G, Brantbilla GL, Candelise L, De Zanche L, Inzitari D, Rasura M, Fieschi C: Italian multicenter study of reversible cerebral ischemic attacks. Part 5. Risk factors and cerebral atherosclerosis. Atherosclerosis 1987:63: 211-224.
17. Kida Y, Sawada T, Kuriyama Y, Naritomi H, Yamaguchi T: Lipoprotein abnormalities in stroke subjects associated with intracranial or extracranial atherosclerosis (in Japanese). Jpn J Stroke 1988:10:431-435.
18. North American Symptomatic Carotid Endar-terectomy Trial: Methods, patient characteristics, and progress. NASCET: Steering Committee. Stroke 1991:22:711-720.
19. Prineas RJ, Crow RS, Blackburn H: The Minnesota Code Manual of Electrocardiogenic Findings: Standards and Procedures for Measurement and Classification. Boston, Wright, 1982.
20. Scholnick HR, Burstein M, Eder HA: A simple method for the detection and identification of various types of hyperlipoproteinemia. Protides Biol Fluids 1972:19:289-292.
21. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentri-fugally separated lipoproteins in human serum. J Clin Invest 1955:34:1345-1353.
22. Cooper GR, Myers GL, Smith SJ, Sampson EJ: Standardization of lipid, lipoprotein, and apo-lipoprotein measurements. Clin Chem 1988: 34:B95-B105.
23. Siedel J, Schiefer S. Rosseneu M, Bergeaud R, De Keersgieter W, Pautz B, Vinaimont N. Zie-genhom J: Immunoturbidimetric method for routine determination of apolipoproteins A-I, A-Il, and B in normo- and hyperlipemic sera compared with inununonephelometry. Clin Chem 1988:34:1821-1825.
24. Nagasaki T, Akanuma Y: A new colorimetric method for the determination of plasma lecithin cholesterol acyltransferase activity. Clin Chim Acta 1977;75:371-375.
25. Bruckert E, Giral P, Salloum J, Kahn JF, Dai-rou F, Truffert J, Reverdy V, Thomas D. Evans J, Grosgogeat Y, De Gennes JL: Carotid stenosis is a powerful predictor of a positive exercise electrocardiogram in a large hvperlipidemic population. Atherosclerosis 1992:92:105-114.
26. Vigna GB. Bolzan M. Romagnoni F. Valerio G. Vitale E, Zuliani G, Fellin R: Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis. Circulation 1992:85: 2205-2211.
27. Sweetnam PM, Bolton CH, Yamell JWG. Bainton D, Baker IA, Ehvood PC, Miller NE: Association of the HDL: and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1994:90:769-774.
28. Gorelick PB: Distribution of atherosclerotic cerebrovascular lesions. Effects of age. race, and sex. Stroke 1993:24(suppl 1): 16-19.
29. Nishimaru K, McHenry LC, Toole JF: Cerebral angiographic and clinical differences in carotid system transient ischemic attacks between American, Caucasian and Japanese patients. Stroke 1984;15:56-59.
30. Fisher CM, Gore L, Okabe N, White PD: Atherosclerosis of the carotid and vertebral arteries - extracranial and intracranial. J Neuropathol Exp Neurol 1965:24:455-476.
31. Mohr JP, Gautier JC, Pessin MS: Internal carotid artery disease: in Barnett HJM, Stein BM, Mohr JP. Yalsu FM (eds): Stroke: Pathophysiology, Diagnosis, and Management, ed 2. New York, Churchill Livingstone, 1992, chap 14, pp 285-335.
32. Hass WK, Fields WS, North RR, Kricheff II, Chase NE, Bauer RB: Joint study of extracranial arterial occlusion. II. Angiography, techniques, sites, and complications. JAMA 1968; 203:961-968.
33. Marzewski DJ, Furlan AJ, Louis PS, Little JR. Modic MT, Williams G: Intracranial internal carotid artery stenosis: Longterm prognosis. Stroke 1982;13:821-824.
34. Craig DR, Meguro K, Watridge C, Robertson JT, Barnett HJM, Fox AJ: Intracranial internal carotid artery stenosis. Stroke 1982: 1 3:825-828.
35. Palomäki H. Kaste M. Raininko R. Salonen O, Juvela S, Sarna S: Risk factors for cervical atherosclerosis in patients with transient ischemic attack or minor ischemic stroke. Stroke 1993: 24:970-975.
36. Szirmai IG. Kamondi A. Magyar H. Juhdsz Cs: Relation of laboratory and clinical variables to the grade of carotid atherosclerosis. Stroke 1993:24:1811-1816.
37. Criqui Mil, Wallace RB, Heiss G, Mishkel M, Schonfeld G, Jones GTL: Cigarette smoking and plasma high-density lipoprotein cholesterol. The lipid research clinics program prevalence study. Circulation 1980;62 (suppl 4):70-76.
38. Franceschini G. Madema P. Sirtori CR: Reverse cholesterol transport: Physiology and pharmacology. Atherosclerosis 1991:88:99-107.
39. Karathanasis SK: Lipoprotein metabolism: High density lipoprotein. Molecular Genetics of Coronary Artery Disease. Candidate Gene and Processes in Atherosclerosis. Basel. Karger, 1992, pp 140-171.
40. Badimon JJ, Fuster V, Badimon L: Role of high density lipoproteins in the regression of atherosclerosis. Circulation 1992;86(suppl 3):86-94.
41. Yui Y. Aoyama T. Morishita H, Takahashi M, Takatsu Y, Kawai C: Serum prostacyclin stabilizing factor is identical to apolipoprotein A-l (Apo A-I). A novel function of apo A-I. J Clin Invest 1988:82:803-807.
42. Rubin EM. Krauss RM. Spangler EA. Ver-stuyft JG. Clift SM: Inhibition of early athero-genesis in transgenic mice by human apolipoprotein A 1. Nature 1991:353:265-267.
43. Schultz JR, Verstuyft JG, Gong EL, Nichols AV, Rubin EM: Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature 1993:365:762-764.